166 related articles for article (PubMed ID: 25109342)
1. The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression.
Yang Z; Yang S; Misner BJ; Liu-Smith F; Meyskens FL
Int J Oncol; 2014 Nov; 45(5):1820-8. PubMed ID: 25109342
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.
Di Maso V; Mediavilla MG; Vascotto C; Lupo F; Baccarani U; Avellini C; Tell G; Tiribelli C; Crocè LS
PLoS One; 2015; 10(12):e0143289. PubMed ID: 26624999
[TBL] [Abstract][Full Text] [Related]
3. Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism.
Yu L; Sun Y; Li J; Wang Y; Zhu Y; Shi Y; Fan X; Zhou J; Bao Y; Xiao J; Cao K; Cao P
J Exp Clin Cancer Res; 2017 Aug; 36(1):110. PubMed ID: 28810896
[TBL] [Abstract][Full Text] [Related]
4. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
Dai H; Li M; Yang W; Sun X; Wang P; Wang X; Su J; Wang X; Hu X; Zhao M
Aging (Albany NY); 2020 Jun; 12(12):11717-11731. PubMed ID: 32530437
[TBL] [Abstract][Full Text] [Related]
6. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
7. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
8. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
9. Metal-Regulatory Transcription Factor-1 Targeted by miR-148a-3p Is Implicated in Human Hepatocellular Carcinoma Progression.
Lyu Z; Yang M; Yang T; Ma M; Yang Z
Front Oncol; 2021; 11():700649. PubMed ID: 34660270
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CTRP6 prevented survival and migration in hepatocellular carcinoma through inactivating the AKT signaling pathway.
Wan X; Zheng C; Dong L
J Cell Biochem; 2019 Oct; 120(10):17059-17066. PubMed ID: 31111552
[TBL] [Abstract][Full Text] [Related]
11. Induction of chemoresistance by all-trans retinoic acid via a noncanonical signaling in multiple myeloma cells.
Liu Z; Li T; Jiang K; Huang Q; Chen Y; Qian F
PLoS One; 2014; 9(1):e85571. PubMed ID: 24416428
[TBL] [Abstract][Full Text] [Related]
12. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol.
Yang Z; Yang S; Misner BJ; Chiu R; Liu F; Meyskens FL
Mol Cancer Ther; 2008 Dec; 7(12):3751-60. PubMed ID: 19074850
[TBL] [Abstract][Full Text] [Related]
14. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
15. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
16. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
17. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
19. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
20. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.
Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
